ReviewCancer chemotherapy and pharmacology2016

A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities.

Dan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.